Targeting once-daily intravenous busulfan in combination with fludarabine before allogeneic hematopoietic cell transplantation.

Jenke, A; Freiberg-Richter, J; Johne, C; Knoth, H; Schleyer, E; Ehninger, G; Bornhäuser, M

Jenke, A; Freiberg-Richter, J; Johne, C; Knoth, H; Schleyer, E; Ehninger, G; Bornhäuser, M.

Bone Marrow Transplant ; 35(6): 627-8, 2005 Mar.

Article in En | MEDLINE | ID: mdl-15756286

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/administration & dosage; Busulfan/pharmacokinetics; Hematopoietic Stem Cell Transplantation/methods; Vidarabine/analogs & derivatives; Busulfan/administration & dosage; Busulfan/blood; Drug Administration Schedule; Humans; Pharmacokinetics; Transplantation, Homologous; Vidarabine/administration & dosage

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Vidarabine / Busulfan / Antineoplastic Combined Chemotherapy Protocols / Hematopoietic Stem Cell Transplantation Limits: Humans Language: En Journal: Bone Marrow Transplant Journal subject: TRANSPLANTE Year: 2005 Document type: Article

Search on Google

Add to My VHL

XML

PubMed Links